Quaker Bio Ventures Lp - Net Worth and Insider Trading

Quaker Bio Ventures Lp Net Worth

The estimated net worth of Quaker Bio Ventures Lp is at least $0 dollars as of 2024-11-13. Quaker Bio Ventures Lp is the 10% Owner of Regado Biosciences Inc and owns about 1,294,021 shares of Regado Biosciences Inc (RGDO) stock worth over $0. Details can be seen in Quaker Bio Ventures Lp's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Quaker Bio Ventures Lp has not made any transactions after 2013-08-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Quaker Bio Ventures Lp

Quaker Bio Ventures Lp Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Quaker Bio Ventures Lp owns 4 companies in total, including Regado Biosciences Inc (RGDO) , Celator Pharmaceuticals Inc (CPXX) , and Ocera Therapeutics Inc (OCRX) among others .

Click here to see the complete history of Quaker Bio Ventures Lp’s form 4 insider trades.

Insider Ownership Summary of Quaker Bio Ventures Lp

Ticker	Comapny	Transaction Date	Type of Owner
RGDO	Regado Biosciences Inc	2013-08-27	10 percent owner
CPXX	Celator Pharmaceuticals Inc	2013-04-29	10 percent owner
OCRX	Ocera Therapeutics Inc	2011-04-06	10 percent owner
		2007-05-30	10 percent owner

Quaker Bio Ventures Lp Latest Holdings Summary

Quaker Bio Ventures Lp currently owns a total of 1 stock. Quaker Bio Ventures Lp owns 1,294,021 shares of Regado Biosciences Inc (RGDO) as of August 27, 2013, with a value of $0.

Latest Holdings of Quaker Bio Ventures Lp

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
RGDO	Regado Biosciences Inc	2013-08-27	1,294,021	0.00	0

Holding Weightings of Quaker Bio Ventures Lp

Quaker Bio Ventures Lp Form 4 Trading Tracker

According to the SEC Form 4 filings, Quaker Bio Ventures Lp has made a total of 0 transactions in Regado Biosciences Inc (RGDO) over the past 5 years. The most-recent trade in Regado Biosciences Inc is the acquisition of 71,810 shares on August 27, 2013, which cost Quaker Bio Ventures Lp around $287,240.

Insider Trading History of Quaker Bio Ventures Lp

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Quaker Bio Ventures Lp Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Quaker Bio Ventures Lp Ownership Network

Ownership Network List of Quaker Bio Ventures Lp

No Data

Ownership Network Relation of Quaker Bio Ventures Lp

Quaker Bio Ventures Lp Owned Company Details

What does Regado Biosciences Inc do?

Who are the key executives at Regado Biosciences Inc?

Quaker Bio Ventures Lp is the 10 percent owner of Regado Biosciences Inc. Other key executives at Regado Biosciences Inc include 10 percent owner Domain Partners Vi, L.p. , Chief Medical Officer Eric Lefebvre , and Chief Financial Officer Christopher Peetz .

Regado Biosciences Inc (RGDO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Regado Biosciences Inc (RGDO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Regado Biosciences Inc (RGDO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Regado Biosciences Inc (RGDO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Regado Biosciences Inc Insider Transactions

No Available Data

What does Celator Pharmaceuticals Inc do?

Who are the key executives at Celator Pharmaceuticals Inc?

Quaker Bio Ventures Lp is the 10 percent owner of Celator Pharmaceuticals Inc. Other key executives at Celator Pharmaceuticals Inc include other: Member of a 10% Group Eric W Roberts , other: See Remarks Section Cdk Associates, L.l.c. , and other: See Remarks Section Caxton Corp .

Celator Pharmaceuticals Inc (CPXX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Celator Pharmaceuticals Inc (CPXX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Celator Pharmaceuticals Inc (CPXX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Celator Pharmaceuticals Inc (CPXX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Celator Pharmaceuticals Inc Insider Transactions

No Available Data

What does Ocera Therapeutics Inc do?

Who are the key executives at Ocera Therapeutics Inc?

Quaker Bio Ventures Lp is the 10 percent owner of Ocera Therapeutics Inc. Other key executives at Ocera Therapeutics Inc include 10 percent owner Brian H Dovey , 10 percent owner Domain Partners Viii, L.p. , and 10 percent owner Dp Viii Associates, L.p. .

Ocera Therapeutics Inc (OCRX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Ocera Therapeutics Inc (OCRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ocera Therapeutics Inc (OCRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Ocera Therapeutics Inc (OCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Ocera Therapeutics Inc Insider Transactions

No Available Data

What does Amicus Therapeutics Inc do?

Who are the key executives at Amicus Therapeutics Inc?

Quaker Bio Ventures Lp is the 10 percent owner of Amicus Therapeutics Inc. Other key executives at Amicus Therapeutics Inc include director & President and CEO Bradley L Campbell , director & Executive Chairman John F Crowley , and Chief People Officer David Michael Clark .

Amicus Therapeutics Inc (FOLD) Insider Trades Summary

Over the past 18 months, Quaker Bio Ventures Lp made no insider transaction in Amicus Therapeutics Inc (FOLD). Other recent insider transactions involving Amicus Therapeutics Inc (FOLD) include a net sale of 232,762 shares made by Bradley L Campbell , a net sale of 333,235 shares made by John F Crowley , and a net sale of 95,000 shares made by Ellen Rosenberg .

In summary, during the past 3 months, insiders sold 30,401 shares of Amicus Therapeutics Inc (FOLD) in total and bought 0 shares, with a net sale of 30,401 shares. During the past 18 months, 803,781 shares of Amicus Therapeutics Inc (FOLD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 803,781 shares.

Amicus Therapeutics Inc (FOLD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Amicus Therapeutics Inc Insider Transactions

No Available Data

Quaker Bio Ventures Lp Mailing Address

Above is the net worth, insider trading, and ownership report for Quaker Bio Ventures Lp. Currently GuruFocus does not have mailing address information for Quaker Bio Ventures Lp.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.